Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Giorgi, D.
Right arrow Articles by Bonomo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giorgi, D.
Right arrow Articles by Bonomo, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 216-217
© 2000 British Society for Rheumatology

Letters to the Editor

Reply

D. Giorgi3 and L. Bonomo1

Lupus Eye Research Unit, Institute of Ophthalmology and
1 Third School of Internal Medicine, ‘La Sapienza’ University, Rome, Italy

We read the letter by Hutchinson et al. with great interest. In fact, a hypothesis considering Devic's neuromyelitis optica as a primary autoimmune disease is most suggestive. Nevertheless, in our opinion some considerations should be made regarding this controversial disease.

Since the first description by Eugène Devic (1894), of patients with neuromyelitis optica, the concurrence of transverse myelopathy with optic neuropathy, both as isolated and in association with various systemic diseases, has been repeatedly reported by . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. Ferreira, P. Marques, E. Carneiro, D. D'Cruz, and G. Gama
Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome
Rheumatology, May 1, 2005; 44(5): 693 - 695.
[Full Text] [PDF]